See more : SES S.A. (SGBAF) Income Statement Analysis – Financial Results
Complete financial analysis of Rite Aid Corporation (RAD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rite Aid Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Sam Woo Construction Group Limited (3822.HK) Income Statement Analysis – Financial Results
- Centaurus Metals Limited (CTM.AX) Income Statement Analysis – Financial Results
- Blue Star Global, Inc. (BUSC) Income Statement Analysis – Financial Results
- Superior Gold Inc. (SUPGF) Income Statement Analysis – Financial Results
- Global Water Technologies, Inc. (GWTR) Income Statement Analysis – Financial Results
Rite Aid Corporation (RAD)
About Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.09B | 24.57B | 24.04B | 21.93B | 21.64B | 21.53B | 22.93B | 30.74B | 26.53B | 25.53B | 25.39B | 26.12B | 25.21B | 25.67B | 26.29B | 24.33B | 17.51B | 17.27B | 16.82B | 16.60B | 15.80B | 15.17B | 14.52B | 14.68B | 12.73B | 11.38B | 6.97B | 5.45B | 4.53B | 4.06B | 4.09B | 3.75B | 3.45B | 3.17B | 2.87B | 2.49B | 1.76B | 1.56B |
| Cost of Revenue | 19.29B | 19.46B | 19.34B | 17.20B | 16.96B | 16.75B | 17.86B | 22.91B | 18.95B | 18.20B | 18.07B | 19.33B | 18.52B | 18.85B | 19.25B | 17.69B | 12.79B | 12.57B | 12.61B | 12.57B | 12.11B | 11.74B | 10.77B | 10.97B | 9.14B | 8.02B | 4.94B | 3.90B | 3.23B | 2.87B | 2.89B | 2.63B | 2.39B | 2.20B | 1.98B | 1.73B | 1.21B | 1.08B |
| Gross Profit | 4.80B | 5.11B | 4.70B | 4.73B | 4.68B | 4.78B | 5.06B | 7.83B | 7.58B | 7.32B | 7.32B | 6.79B | 6.69B | 6.82B | 7.04B | 6.64B | 4.72B | 4.70B | 4.21B | 4.03B | 3.69B | 3.43B | 3.75B | 3.71B | 3.59B | 3.36B | 2.03B | 1.55B | 1.30B | 1.18B | 1.19B | 1.12B | 1.05B | 973.00M | 885.00M | 756.30M | 546.80M | 485.50M |
| Gross Profit Ratio | 19.94% | 20.78% | 19.57% | 21.56% | 21.61% | 22.20% | 22.09% | 25.46% | 28.56% | 28.69% | 28.82% | 26.01% | 26.54% | 26.58% | 26.76% | 27.28% | 26.94% | 27.21% | 25.02% | 24.29% | 23.36% | 22.60% | 25.83% | 25.29% | 28.23% | 29.52% | 29.06% | 28.41% | 28.77% | 29.18% | 29.22% | 29.83% | 30.55% | 30.67% | 30.85% | 30.42% | 31.13% | 31.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.60B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 3.37B | 3.46B | 3.71B | 2.64B | 2.39B | 1.43B | 1.10B | 932.20M | 1.01B | 847.70M | 781.90M | 732.90M | 700.10M | 613.60M | 506.50M | 346.60M | 304.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 483.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 352.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.58B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 4.20B | 4.65B | 4.21B | 2.94B | 2.67B | 1.60B | 1.22B | 1.03B | 1.11B | 946.00M | 875.40M | 826.20M | 784.50M | 690.40M | 567.50M | 390.90M | 341.70M |
| Cost & Expenses | 24.19B | 24.50B | 24.00B | 21.79B | 21.56B | 21.40B | 22.64B | 29.92B | 25.65B | 24.76B | 24.67B | 25.86B | 24.98B | 25.43B | 26.24B | 24.06B | 17.16B | 16.88B | 16.37B | 16.22B | 15.52B | 15.94B | 15.42B | 15.18B | 12.08B | 10.69B | 6.55B | 5.12B | 4.26B | 3.98B | 3.84B | 3.51B | 3.22B | 2.98B | 2.67B | 2.30B | 1.60B | 1.42B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M | 202.77M | 200.07M | 449.57M | 397.61M | 424.59M | 515.42M | 529.26M | 547.58M | 515.76M | 477.63M | 449.60M | 275.22M | 277.02M | 294.87M | 313.50M | 396.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M | 386.06M | 407.37M | 509.21M | 416.63M | 403.74M | 414.11M | 440.58M | 505.55M | 534.24M | 586.21M | 472.47M | 270.31M | 249.76M | 246.74M | 264.29M | 285.33M | 349.84M | 384.07M | 501.00M | 302.60M | 274.20M | 168.10M | 118.70M | 98.60M | 95.70M | 98.30M | 93.50M | 93.30M | 84.40M | 76.80M | 61.00M | 44.30M | 37.20M |
| EBITDA | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M | 514.90M | 695.08M | 1.32B | 1.30B | 1.17B | 1.45B | 702.51M | 762.44M | 778.10M | -2.91B | -1.08B | 834.33M | 918.46M | 718.57M | 686.98M | 681.40M | -17.56M | -11.40M | 95.52M | 1.21B | 964.00M | 659.70M | 443.20M | 372.40M | 170.10M | 345.90M | 336.30M | 320.40M | 272.90M | 268.30M | 247.40M | 195.40M | 177.00M |
| EBITDA Ratio | 0.74% | 1.50% | 1.56% | 2.13% | 2.04% | 2.39% | 3.03% | 4.30% | 4.89% | 4.57% | 4.46% | 2.69% | 3.02% | 3.03% | 10.62% | 3.45% | 3.84% | 4.13% | 4.27% | 4.14% | 4.31% | -0.12% | -0.08% | 0.65% | 9.52% | 8.47% | 9.46% | 8.14% | 8.21% | 4.19% | 8.47% | 8.97% | 9.29% | 8.60% | 9.35% | 9.95% | 11.12% | 11.32% |
| Operating Income | -98.15M | 72.62M | 47.14M | 139.42M | 83.98M | 128.84M | 287.71M | 812.91M | 881.09M | 762.57M | 717.51M | 261.92M | 256.90M | 243.86M | 2.21B | 366.78M | 402.48M | 463.10M | 471.83M | 422.69M | 396.07M | -367.40M | -395.47M | -405.47M | 909.00M | 689.80M | 491.60M | 324.50M | 273.80M | 74.40M | 247.60M | 242.80M | 227.10M | 188.50M | 191.50M | 186.40M | 151.10M | 139.80M |
| Operating Income Ratio | -0.41% | 0.30% | 0.20% | 0.64% | 0.39% | 0.60% | 1.25% | 2.64% | 3.32% | 2.99% | 2.83% | 1.00% | 1.02% | 0.95% | 8.39% | 1.51% | 2.30% | 2.68% | 2.81% | 2.55% | 2.51% | -2.42% | -2.72% | -2.76% | 7.14% | 6.06% | 7.05% | 5.96% | 6.04% | 1.83% | 6.06% | 6.48% | 6.59% | 5.94% | 6.68% | 7.50% | 8.60% | 8.94% |
| Total Other Income/Expenses | -658.26M | -614.88M | -20.16M | -221.03M | -673.45M | -172.39M | -239.19M | -534.51M | -454.27M | -512.35M | -710.01M | -261.89M | 9.84M | 26.76M | -2.63B | -544.94M | -388.90M | -419.85M | -168.47M | -403.12M | -167.64M | -405.44M | -887.34M | -710.27M | -709.40M | -159.80M | -164.60M | -68.30M | -42.30M | -28.70M | -33.00M | -40.80M | -52.40M | -54.70M | -40.30M | -32.20M | -18.10M | -11.90M |
| Income Before Tax | -756.40M | -542.26M | -120.23M | -81.61M | -589.48M | -43.55M | 48.52M | 278.40M | 426.82M | 250.22M | 7.51M | -392.26M | -545.58M | -479.92M | -2.58B | -273.50M | 13.58M | 43.25M | 134.01M | 34.52M | -167.64M | -772.84M | -1.28B | -1.12B | 199.60M | 530.00M | 258.90M | 256.20M | 231.50M | 45.70M | 214.60M | 202.00M | 174.70M | 133.80M | 154.30M | 156.60M | 137.80M | 127.90M |
| Income Before Tax Ratio | -3.14% | -2.21% | -0.50% | -0.37% | -2.72% | -0.20% | 0.21% | 0.91% | 1.61% | 0.98% | 0.03% | -1.50% | -2.16% | -1.87% | -9.82% | -1.12% | 0.08% | 0.25% | 0.80% | 0.21% | -1.06% | -5.09% | -8.84% | -7.60% | 1.57% | 4.66% | 3.71% | 4.70% | 5.11% | 1.13% | 5.25% | 5.39% | 5.07% | 4.22% | 5.38% | 6.30% | 7.84% | 8.18% |
| Income Tax Expense | -6.47M | -3.78M | -20.16M | 387.61M | 77.48M | 305.99M | 44.44M | 112.94M | -1.68B | 804.00K | -110.60M | -23.69M | 9.84M | 26.76M | 329.26M | 802.70M | -13.24M | -1.23B | -168.47M | -48.80M | -41.94M | -11.75M | 148.96M | 8.00K | 55.90M | 213.60M | 98.40M | 97.30M | 90.20M | 19.50M | 82.20M | 78.00M | 67.40M | 51.90M | 59.10M | 62.80M | 59.80M | 60.00M |
| Net Income | -749.94M | -538.48M | -100.07M | -469.22M | -422.21M | 943.47M | 4.05M | 165.47M | 2.11B | 249.41M | 118.11M | -368.57M | -555.42M | -506.68M | -2.92B | -1.08B | 26.83M | 1.27B | 302.48M | 83.31M | -112.08M | -827.68M | -1.59B | -1.14B | 143.70M | 316.40M | 115.30M | 158.90M | 141.30M | 9.30M | 132.40M | 124.00M | 107.30M | 102.10M | 95.20M | 140.90M | 78.00M | 62.50M |
| Net Income Ratio | -3.11% | -2.19% | -0.42% | -2.14% | -1.95% | 4.38% | 0.02% | 0.54% | 7.95% | 0.98% | 0.47% | -1.41% | -2.20% | -1.97% | -11.09% | -4.44% | 0.15% | 7.37% | 1.80% | 0.50% | -0.71% | -5.46% | -10.95% | -7.79% | 1.13% | 2.78% | 1.65% | 2.92% | 3.12% | 0.23% | 3.24% | 3.31% | 3.11% | 3.22% | 3.32% | 5.67% | 4.44% | 4.00% |
| EPS | -13.71 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 43.40 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 47.20 | 10.05 | 2.27 | -4.34 | -35.03 | -111.20 | -88.19 | -35.80 | -14.80 | 6.30 | 9.50 | 16.70 | 0.90 | 7.50 | 7.10 | 3.25 | 3.10 | 2.85 | 4.30 | 2.40 | 1.90 |
| EPS Diluted | -13.64 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 41.60 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 37.80 | 8.25 | 2.23 | -4.34 | -35.03 | -95.73 | -88.19 | -35.80 | -14.80 | 6.30 | 9.20 | 16.70 | 0.90 | 7.30 | 7.00 | 3.25 | 3.05 | 2.85 | 4.30 | 2.40 | 1.90 |
| Weighted Avg Shares Out | 54.68M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 52.22M | 51.22M | 48.56M | 46.11M | 44.48M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 26.20M | 26.98M | 20.67M | 25.85M | 23.62M | 14.29M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
| Weighted Avg Shares Out (Dil) | 54.99M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 53.04M | 52.12M | 50.89M | 48.95M | 45.36M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 33.83M | 31.70M | 26.29M | 25.85M | 23.62M | 16.60M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
Rite Aid Reportedly Preparing For Bankruptcy Amid Opioid Lawsuits And $3.3 Billion Debt
Rite Aid could become the latest company to declare bankruptcy as a result of lawsuits filed in the wake of the opioid crisis.
Rite Aid reportedly prepares to file for bankruptcy to shield it from opioid lawsuits
The Chapter 11 filing would cover Rite Aid's more than $3.3 billion debt load and pending legal allegations that it oversupplied prescription painkillers, the Journal reported.
Drug retailer Rite Aid prepares to file for bankruptcy - WSJ
Rite Aid Corp is preparing to file for bankruptcy in coming weeks to address lawsuits the company is facing over its alleged role in the sale of opioids, the Wall Street Journal reported on Friday, citing people familiar with the...
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Analysts said blockbuster weight loss drugs like Wegovy are minimally profitable for retailers like Walmart – and may even come with slight margin headwinds.
TTOO vs. RAD Stock: Which New Meme Stock Is the Worst Buy?
Earlier this week, InvestorPlace's Thomas Yeung posed an interesting question: Could Rite Aid (NYSE: RAD ) become the next big meme stock? As meme stocks surged last week, The Wall Street Journal flagged the struggling pharmaceutical chain as a likely contender...
Could Rite Aid Become the Next AMC Meme Stock?
Last week, meme investors “discovered” Rite Aid (NYSE: RAD ), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown.
Rite Aid Short Squeeze Takes RAD Stock 6% Higher
Shares of Rite Aid (NYSE: RAD ) stock are bouncing higher on Friday, up about 5.5% at the moment. At today's high, RAD stock was up roughly 23%.
Best Penny Stocks To Buy? 3 To Watch With Unusual Options Action
Retail investors are on the prowl for the best penny stocks to invest in. We've touched on several unique trends currently influencing the stock market, including sentiment-driven sympathy trades.
Why Shares of Rite Aid Soared This Week
Rite Aid has not had a profitable year since 2018. The company reported a loss of $306 million in its last quarterly report.
Rite Aid Announces Availability of Flu and RSV Vaccine Appointments at All Locations
PHILADELPHIA--(BUSINESS WIRE)--As August marks Immunization Awareness Month, Rite Aid (NYSE: RAD) today announced appointments for flu and RSV vaccines are available at all store locations, including Bartell Drugs in the Pacific Northwest. Customers can now schedule appointments to protect themselves...
Source: https://incomestatements.info
Category: Stock Reports